Experts from Indian Council for Medical Research (ICMR) said that the Covid-19 will subsequently reach its endemic stage, just like…
Sanofi and GSK received approval for their Phase 3 clinical study in India, to assess the safety, efficacy and immunogenicity…
New Delhi: The World Health Organization (WHO) on Wednesday included lifesaving interleukin-6 receptor blockers--tocilizumab and sarilumab- in its list of…
Close to 50 adults and children who have recovered from Covid-19 have been admitted to a private facility here with…
A study by Stanford University School of Medicine investigators hints that people with COVID-19 may experience milder symptoms if certain…
A new COVID-19 strain called 'Lambda' is much more dangerous than the Delta variant, said the UK Health Ministry adding…
Delta variant of coronavirus is eight times less sensitive to antibodies generated by vaccines, a new study claims. This could…
After rise in black fungus cases, doctors have come across a new challenge inflicting Covid survivors-bone death. As per reports,…
Kolkata-based medical research body ICMR-NICED has submitted a proposal to the Department of Biotechnology under the Union Ministry of Science…
Japanese scientists are scanning the possibility of using an anti-malarial drug called mefloquine. In a breakthrough study, a team of scientists from Tokyo University of Science…